Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta‐analysis
European Journal of Clinical Investigation2022Vol. 52(11), pp. e13855–e13855
Citations Over TimeTop 10% of 2022 papers
Zhiwei Yan, Yang Liu, Wei Li, Wei Li, Xiaopeng Zhao, Weichun Lin, Jing Zhang, Shuchun Yu, Jianyong Ma, Jingfeng Wang, Peng Yu, Weiguang Li, Weiguang Li, Xiao Liu
Abstract
Higher levels of FIB-4 and NFS are related to an increased risk of cardiovascular events, cardiovascular mortality and all-cause mortality in patients with cardiovascular disease.
Related Papers
- → Noninvasive Parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease(2012)102 cited
- → Nonalcoholic fatty liver disease and its association with cardiovascular disease(2009)61 cited
- → Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis(2015)22 cited
- → Prognostic value of tumor size in thymic epithelial tumors: A systematic review and meta-analysis(2022)3 cited
- → Prognostic significance of p16INK4a alteration in soft tissue sarcomas: A meta-analysis(2017)